Universal Health Services (UHS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Werte in diesem Artikel
Universal Health Services (UHS) reported $4.28 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 9.6%. EPS of $5.35 for the same period compares to $4.31 a year ago.The reported revenue represents a surprise of +1.51% over the Zacks Consensus Estimate of $4.22 billion. With the consensus EPS estimate being $4.85, the EPS surprise was +10.31%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Universal Health Services performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Admissions - Behavioral health: 118,974 versus 122,616 estimated by two analysts on average.Net Revenues- Behavioral health services: $1.88 billion versus the four-analyst average estimate of $1.86 billion. The reported number represents a year-over-year change of +8.6%.Net Revenues- Acute care hospital services: $2.4 billion versus $2.37 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +10.5% change.Operating Income- Behavioral Health Care Services: $396.46 million versus $368.68 million estimated by three analysts on average.Operating Income- Acute Care Hospital Services: $225.22 million versus the three-analyst average estimate of $226.87 million.View all Key Company Metrics for Universal Health Services here>>>Shares of Universal Health Services have returned -12.6% over the past month versus the Zacks S&P 500 composite's +4.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They includeStock #1: A Disruptive Force with Notable Growth and ResilienceStock #2: Bullish Signs Signaling to Buy the DipStock #3: One of the Most Compelling Investments in the MarketStock #4: Leader In a Red-Hot Industry Poised for GrowthStock #5: Modern Omni-Channel Platform Coiled to SpringMost of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.Download Atomic Opportunity: Nuclear Energy's Comeback free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Universal Health Services, Inc. (UHS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Q2 und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Q2
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q2
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Q2 Holdings Inc
Analysen zu Q2 Holdings Inc
Datum | Rating | Analyst | |
---|---|---|---|
13.08.2019 | Q2 Buy | Compass Point | |
01.03.2019 | Q2 Buy | Needham & Company, LLC | |
19.12.2018 | Q2 Buy | BTIG Research | |
09.08.2018 | Q2 Buy | Needham & Company, LLC | |
11.05.2018 | Q2 Neutral | BTIG Research |
Datum | Rating | Analyst | |
---|---|---|---|
11.05.2018 | Q2 Neutral | BTIG Research | |
18.11.2016 | Q2 Sector Weight | Pacific Crest Securities Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Q2 Holdings Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen